Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
JA ›
JABRYUS
Trademark search for:
JABRYUS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-11-08 — Application filed
2021-11-11 — Application filed
2021-11-16 — Application filed
2022-08-08 — Approved for pub - principal register
2022-08-08 — Assigned to examiner
2022-08-24 — Notification of notice of publication e-mailed
2022-09-13 — Published for opposition
2022-09-13 — Official gazette publication confirmation e-mailed
2022-11-08 — Noa e-mailed - sou required from applicant
2023-02-21 — Assigned to examiner
2023-03-27 — Attorney/dom.rep.revoked and/or appointed
2023-03-27 — Sou teas extension received
2023-03-27 — Teas change of owner address received
2023-03-27 — Teas change of correspondence received
2023-03-27 — Sou extension 1 filed
2023-03-27 — Sou extension 1 granted
2023-03-27 — Applicant/correspondence changes (non-responsive) entered
2023-03-27 — Teas revoke/app/change addr of atty/dom rep received
2023-03-29 — Notice of approval of extension request e-mailed
2023-09-27 — Sou teas extension received
2023-09-27 — Sou extension 2 filed
2023-09-27 — Sou extension 2 granted
2023-09-29 — Notice of approval of extension request e-mailed
2024-06-10 — Application abandoned
2024-06-10 — Final status recorded
2024-07-12 — Application abandoned
Owner Information
Pfizer Inc.
New York , NY
Pfizer Inc.
New York , NY
Correspondent
Janina Gorbach Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192 United States
Filing Details
Filing Date:
2021-11-08
Status Date:
2024-06-10
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.